Patent · US Active

Diabetes therapy

US9149478B2 · kind B2 · utility

36Cited by

115References

8Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Thomas KLEIN · Radolfzell, DE
Michael Mark · Biberach an der Riß, DE
Leo Thomas · Biberach, DE

Key dates

Filing date	Jun 23, 2011
Grant date	Oct 6, 2015
Priority date	—
Expiry date	Jan 6, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a DPP-4 inhibitor and a long-acting insulin. The invention further relates to a DPP-4 inhibitor for subcutaneous or transdermal use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.